Tatva Chintan Pharma Chem Ltd has reappointed Chintan Nitinkumar Shah as Managing Director, extending his tenure until January 31, 2026. The decision was ratified at the company’s 28th Annual General Meeting, reflecting continued confidence in Shah’s leadership.
Key Highlights
-
Shah will receive a fixed gross remuneration of Rs 1.65 crore per annum, excluding PF, gratuity, and superannuation.
-
His compensation includes Rs 50.8 lakh in basic salary and Rs 1.14 crore in allowances, with additional perquisites such as medical insurance and companyprovided facilities.
-
In case of inadequate profits, the approved package will serve as minimum remuneration under Schedule V of the Companies Act.
Strategic Context
-
Shah has been associated with Tatva Chintan since its inception in 1996 and brings over 28 years of experience in business development, R&D, and global operations.
-
His reappointment signals stability as the company expands its specialty chemicals portfolio and global footprint.
Sources: Tatva Chintan AGM Notice, Economic Times, Company Website.